Clinical Trial Update: Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial assesses sequential systemic therapy followed by intraperitoneal paclitaxel for gastric cancer with peritoneal carcinomatosis, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Peritoneal Carcinomatosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of California, Irvine | Conditions: Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING